Colgate-Palmolive (India) Limited (COLPAL.NS)
Mumbai, IN
Colgate-Palmolive (India) Limited is an Indian company dedicated to the manufacturing and marketing of personal and oral hygiene products. Its comprehensive oral care portfolio, primarily sold under the Colgate brand, features items such as toothpastes, toothpowders, toothbrushes, oil pulling solutions, mouthwashes, and dental gels, alongside various specialized dental preparations. Beyond oral hygiene, it also supplies soaps, cosmetics, and other toiletry items. Under the Palmolive label, it markets personal care essentials like shower gels and liquid hand soaps. The company additionally distributes its goods internationally through exports. Founded in 1937, the firm maintains its corporate headquarters in Mumbai, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.28% | +0.41% | -0.57% | -3.46% | +0.10% | +4.01% | -14.00% | +35.44% | +32.23% | +158.74% | +2,964.44% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 5 | 0 |
| Hold | 8 | -1 |
| Sell | 5 | 0 |
| Strong Sell | 6 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+0.6% Q1'26: +9.9% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%-7.8% Q1'26: -0.5% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+27.2% Q1'26: +60.2% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+28.6% ★ Q1'26: +29.7% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+787.0% ★ Q1'26: +869.6% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+0.0% Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×0.03× ★ Q1'26: 0.02× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2011 actual |
Mar 2012 actual |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 23 Rev. Ana. 24 EPS Ana. |
Mar 2027 5 Rev. Ana. 8 EPS Ana. |
Mar 2028 21 Rev. Ana. 24 EPS Ana. |
Mar 2029 10 Rev. Ana. 11 EPS Ana. |
Mar 2030 10 Rev. Ana. 11 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
22.86B
est: 22.94B (-0.3%)
|
26.92B
est: 26.67B (+0.9%)
|
31.62B
est: 31.48B (+0.5%)
|
35.77B
est: 36.36B (-1.6%)
|
39.80B
est: 40.11B (-0.8%)
|
38.65B
est: 41.39B (-6.6%)
|
39.78B
est: 43.07B (-7.6%)
|
41.85B
est: 43.31B (-3.4%)
|
44.58B
est: 45.10B (-1.2%)
|
45.19B
est: 46.29B (-2.4%)
|
48.38B
est: 47.88B (+1.0%)
|
50.66B
est: 51.43B (-1.5%)
|
51.88B
est: 52.31B (-0.8%)
|
56.44B
est: 56.43B (+0.0%)
|
59.99B
est: 61.30B (-2.1%)
|
59.73B
59.07B – 60.17B
-2.6% YoY
|
64.19B
63.78B – 65.07B
+7.5% YoY
|
68.79B
65.61B – 73.35B
+7.2% YoY
|
76.76B
74.71B – 79.87B
+11.6% YoY
|
83.95B
81.71B – 87.35B
+9.4% YoY
|
| EBITDA |
5.56B
est: 6.27B (-11.3%)
|
6.29B
est: 6.71B (-6.3%)
|
6.62B
est: 7.90B (-16.2%)
|
6.68B
est: 8.63B (-22.6%)
|
8.24B
est: 9.08B (-9.2%)
|
9.49B
est: 9.13B (+4.0%)
|
9.45B
est: 9.70B (-2.5%)
|
11.40B
est: 10.71B (+6.4%)
|
13.04B
est: 11.86B (+10.0%)
|
12.51B
est: 13.53B (-7.5%)
|
15.40B
est: 12.66B (+21.7%)
|
15.92B
est: 13.79B (+15.5%)
|
15.89B
est: 15.05B (+5.6%)
|
19.58B
est: 16.26B (+20.4%)
|
20.97B
est: 19.70B (+6.4%)
|
19.14B
18.93B – 19.29B
-2.8% YoY
|
20.57B
20.44B – 20.86B
+7.5% YoY
|
22.05B
21.03B – 23.51B
+7.2% YoY
|
24.60B
23.95B – 25.60B
+11.6% YoY
|
26.91B
26.19B – 28.00B
+9.4% YoY
|
| EBIT |
5.22B
est: 4.63B (+12.8%)
|
5.90B
est: 4.81B (+22.6%)
|
6.18B
est: 6.38B (-3.1%)
|
6.17B
est: 7.08B (-12.9%)
|
7.49B
est: 7.58B (-1.2%)
|
8.38B
est: 7.77B (+7.8%)
|
8.12B
est: 8.23B (-1.3%)
|
9.83B
est: 8.58B (+14.6%)
|
11.45B
est: 9.84B (+16.4%)
|
10.53B
est: 11.27B (-6.5%)
|
13.57B
est: 10.11B (+34.3%)
|
14.15B
est: 11.01B (+28.5%)
|
14.15B
est: 12.02B (+17.7%)
|
17.86B
est: 12.98B (+37.6%)
|
19.34B
est: 19.46B (-0.6%)
|
18.90B
18.70B – 19.04B
-2.8% YoY
|
20.32B
20.19B – 20.60B
+7.5% YoY
|
21.77B
20.76B – 23.22B
+7.2% YoY
|
24.30B
23.65B – 25.28B
+11.6% YoY
|
26.57B
25.86B – 27.65B
+9.4% YoY
|
| Net Income |
4.03B
est: 4.94B (-18.6%)
|
4.46B
est: 4.65B (-4.0%)
|
4.97B
est: 5.28B (-5.9%)
|
5.40B
est: 5.74B (-5.9%)
|
5.59B
est: 6.03B (-7.3%)
|
5.81B
est: 5.79B (+0.3%)
|
5.77B
est: 5.97B (-3.3%)
|
6.73B
est: 6.09B (+10.6%)
|
7.76B
est: 7.01B (+10.7%)
|
8.16B
est: 7.87B (+3.7%)
|
10.35B
est: 8.20B (+26.2%)
|
10.78B
est: 8.94B (+20.7%)
|
10.47B
est: 9.75B (+7.3%)
|
13.24B
est: 10.54B (+25.6%)
|
14.37B
est: 14.58B (-1.4%)
|
13.42B
13.07B – 13.80B
-7.9% YoY
|
14.31B
14.03B – 14.70B
+6.7% YoY
|
15.72B
14.49B – 16.96B
+9.9% YoY
|
17.82B
17.20B – 18.76B
+13.3% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
5.88B
est: 8.62B (-31.8%)
|
7.01B
est: 10.23B (-31.4%)
|
9.60B
est: 11.48B (-16.3%)
|
8.13B
est: 13.25B (-38.7%)
|
10.06B
est: 13.58B (-25.9%)
|
7.59B
est: 13.96B (-45.6%)
|
8.52B
est: 11.59B (-26.5%)
|
8.80B
est: 12.95B (-32.0%)
|
9.07B
est: 8.66B (+4.7%)
|
9.64B
est: 13.48B (-28.5%)
|
9.96B
est: 14.03B (-29.0%)
|
10.34B
est: 15.28B (-32.3%)
|
10.16B
est: 16.68B (-39.1%)
|
11.77B
est: 18.02B (-34.7%)
|
12.77B
est: 13.87B (-8.0%)
|
13.48B
13.33B – 13.58B
-2.8% YoY
|
14.49B
14.39B – 14.69B
+7.5% YoY
|
15.52B
14.81B – 16.55B
+7.2% YoY
|
17.32B
16.86B – 18.03B
+11.6% YoY
|
18.95B
18.44B – 19.71B
+9.4% YoY
|
| EPS |
14.80
est: 15.60 (-5.2%)
|
16.42
est: 16.34 (+0.5%)
|
18.27
est: 19.44 (-6.0%)
|
19.85
est: 18.44 (+7.7%)
|
20.55
est: 20.73 (-0.9%)
|
21.37
est: 22.85 (-6.5%)
|
21.23
est: 22.29 (-4.7%)
|
24.76
est: 24.33 (+1.8%)
|
28.52
est: 27.93 (+2.1%)
|
30.02
est: 30.13 (-0.4%)
|
38.07
est: 35.09 (+8.5%)
|
39.65
est: 39.14 (+1.3%)
|
38.50
est: 37.61 (+2.4%)
|
48.67
est: 48.01 (+1.4%)
|
52.83
est: 52.56 (+0.5%)
|
49.34
48.06 – 50.75
-6.1% YoY
|
52.63
51.60 – 54.06
+6.7% YoY
|
57.82
53.27 – 62.37
+9.9% YoY
|
65.54
63.26 – 68.99
+13.3% YoY
|
—
— – —
-100.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Schwab Emerging Markets Equity ETF SCHE | 0.03% | 3.30M | 0.06% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Prabha Narasimhan | MD, Chief Executive Officer & Director | 69M | female |
| Madukkakuzy Sebastian Jacob | Chief Financial Officer & Whole-Time Director | 42M | male |
| Jaikishan Shah | Company Secretary & Compliance Officer | — | male |
| Niraj Kumar | Managing Director of Colgate-Palmolive ACI Bangladesh Pvt. Ltd. | — | male |
| Priyan Pillay | Executive Vice President of Legal | — | male |
| Ruchir Bhatnagar | Executive Vice President of Customer Development | — | male |
| Shilpashree Muniswamappa | Director of ESG & Communications | — | female |
| Balaji Sreenivasan | Executive Vice President of Human Resources | — | male |
| Swati Agarwal | Executive Vice President of India Global Technology Center | — | female |
| Gunjit Jain | Executive Vice President of Marketing | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for COLPAL.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
